+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Batten Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Batten Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
From
Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Uncomplicated Urinary Tract Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
From
Age-Related Macular Degeneration (AMD) - Pipeline Insight, 2025 - Product Thumbnail Image

Age-Related Macular Degeneration (AMD) - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 280 Pages
  • Global
From
From
From
Mitochondrial Myopathies- Pipeline Insight, 2025 - Product Thumbnail Image

Mitochondrial Myopathies- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mitral Valve Insufficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Mitral Valve Insufficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025 - Product Thumbnail Image

Molybdenum Cofactor Deficiency (MOCOD)emerging - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Mucopolysaccharidosis II - Pipeline Insight, 2025 - Product Thumbnail Image

Mucopolysaccharidosis II - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2025 - Product Thumbnail Image

Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025 - Product Thumbnail Image

Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vascular Ehlers-Danlos Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Ehlers-Danlos Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Bronchitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Bronchitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
GABA Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

GABA Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Endocrine Tumor - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatic Endocrine Tumor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tularemia - Pipeline Insight, 2025 - Product Thumbnail Image

Tularemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more